These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18763607)

  • 1. [Leukemic dendritic cells].
    Gal'tseva IV; Pashin LE; Savchenko VG
    Ter Arkh; 2008; 80(7):84-8. PubMed ID: 18763607
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability.
    Narita M; Kuroha T; Watanabe N; Hashimoto S; Tsuchiyama J; Tochiki N; Saitoh A; Satoh N; Furukawa T; Toba K; Fuse I; Aizawa Y; Takahashi M
    Acta Haematol; 2008; 120(2):91-9. PubMed ID: 18948686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antigen-presenting cells in cellular immunotherapy].
    Narita M; Furukara T
    Rinsho Ketsueki; 2002 May; 43(5):368-73. PubMed ID: 12096489
    [No Abstract]   [Full Text] [Related]  

  • 4. How to restore normal innate antitumor immunity in acute leukemia?
    Costello RT
    Leuk Res; 2009 May; 33(5):613. PubMed ID: 18952282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of interleukin-12 expressing dendritic cells for the treatment of animal model of leukemia.
    Tsai BY; Lin YL; Chiang BL
    Exp Biol Med (Maywood); 2009 Aug; 234(8):952-60. PubMed ID: 19491372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
    Schmidt K; Seeger K; Scheibenbogen C; Bender R; Abdulla M; Süssmilch S; Salama A; Moldenhauer A
    J Leukoc Biol; 2009 Mar; 85(3):563-73. PubMed ID: 19129484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
    Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
    Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells.
    Ge W; Ma X; Li X; Wang Y; Li C; Meng H; Liu X; Yu Z; You S; Qiu L
    Leuk Res; 2009 Jul; 33(7):948-57. PubMed ID: 19233469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Philadelphia chromosome-positive blastic plasmacytoid dendritic cell leukemia.
    Adams RL; McCarthy C; Bird RJ
    Cancer Genet Cytogenet; 2009 Dec; 195(2):186-8. PubMed ID: 19963123
    [No Abstract]   [Full Text] [Related]  

  • 10. Before they were gut dendritic cells.
    Rescigno M
    Immunity; 2009 Sep; 31(3):454-6. PubMed ID: 19766089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell vaccines in acute leukaemia.
    Duncan C; Roddie H
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):521-41. PubMed ID: 18790453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dendritic cells transfected with recombinant adenovirus Ad5F35-LMP2 induces LMP2 specific immunity mediated by cytotoxic T lymphocytes in vitro].
    Mo WN; Zhou L; Wang Z; Tang AZ; Huang GW; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):254-6. PubMed ID: 19105335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helping the helpers!
    Ma CS; Tangye SG
    Immunity; 2009 Jul; 31(1):12-4. PubMed ID: 19604489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
    Tan YF; Sim GC; Habsah A; Leong CF; Cheong SK
    Malays J Pathol; 2008 Dec; 30(2):73-9. PubMed ID: 19291915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of CD47 in vivo influences thymic dendritic cell subset proportions but not negative selection of thymocytes.
    Guimont-Desrochers F; Beauchamp C; Chabot-Roy G; Dugas V; Hillhouse EE; Dusseault J; Langlois G; Gautier-Ethier P; Darwiche J; Sarfati M; Lesage S
    Int Immunol; 2009 Feb; 21(2):167-77. PubMed ID: 19147837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of dendritic cells by HMGB1 is associated with lymph node metastasis of human colon cancer.
    Kusume A; Sasahira T; Luo Y; Isobe M; Nakagawa N; Tatsumoto N; Fujii K; Ohmori H; Kuniyasu H
    Pathobiology; 2009; 76(4):155-62. PubMed ID: 19571604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of innate immune responses in autoimmune disease development.
    Waldner H
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of antigen-unloaded immature dendritic cells on antileukemic T-cell cytotoxicity.
    Harnack U; Pecher G
    Anticancer Res; 2008; 28(5A):2831-5. PubMed ID: 19035318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Malononitrilamides (FK778) on phenotypic properties of human peripheral dendritic cells.
    Hou J; Wei JM; Yu ZY; Xu Y; Li J; Tang DN
    Transplant Proc; 2009 Jun; 41(5):1859-61. PubMed ID: 19545744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
    Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M
    Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.